Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIRCCa trial of cediranib plus carboplatin-paclitaxel in recurrent or metastatic cervical cancer
ISRCTN23516549Phase 2Completed
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Jun 2010
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of cediranib, carboplatin and paclitaxel in Cervical Cancer (CC) (2 arms), sponsored by NHS Greater Glasgow and Clyde. Primary endpoint: Progression-free survival. Started Jun 2010; status: completed.
02
Drugs
cediranibcarboplatinpaclitaxel
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on ISRCTN23516549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN23516549.